|
End-of-day quote
Canadian Securities Exchange
02/10/2026
|
5-day change | 1st Jan Change | ||
| 0.0300 CAD | 0.00% |
|
-14.29% | -60.00% |
| Market Cap | 39.22L 27.51L 24.44L 22.81L 20.79L 26Cr 39.58L 2.76Cr 1.07Cr 14Cr 1.03Cr 1.01Cr 43Cr | P/E 2024 |
-1.85x | P/E 2025 | -3.69x |
|---|---|---|---|---|---|
| Enterprise Value | 54.27L 38.07L 33.83L 31.57L 28.78L 37Cr 54.78L 3.82Cr 1.48Cr 19Cr 1.43Cr 1.4Cr 60Cr | EV / Sales 2024 |
0.67x | EV / Sales 2025 | 0.89x |
| Free-Float |
82.94% | Yield 2024 * |
-
| Yield 2025 | - |
Canadian Securities ExchangeCAD
| Markets | Quality | ||
|---|---|---|---|
Canadian Securities Exchange
| HERB | End-of-day quote | |
Canadian Securities Exchange
| HERB | Delayed | |
|
OTC Markets
| LUFFF | Delayed | |
|
Deutsche Boerse AG
| HA9 | Delayed |
| 1 week | -14.29% | ||
| Current month | +20.00% | ||
| 3 months | -40.00% | ||
| 6 months | -33.33% | ||
| Current year | -60.00% |
| 1 week | 0.02 |  | 0.04 |
| 1 month | 0.02 | | 0.04 |
| Current year | 0.02 | | 0.12 |
| 1 year | 0.02 | | 0.13 |
| 3 years | 0.02 | | 0.13 |
| 5 years | 0.02 | | 0.25 |
| 10 years | 0.02 | | 9.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Philip Campbell
CEO | Chief Executive Officer | - | 15/05/2020 |
Jason Vandenberg
DFI | Director of Finance/CFO | 49 | 18/01/2022 |
Aron Tegenfeldt
PRN | Corporate Officer/Principal | - | 01/08/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Philip Campbell
BRD | Director/Board Member | - | 15/05/2020 |
Drew Malcolm
BRD | Director/Board Member | - | 24/06/2020 |
Herb Dhaliwal
CHM | Chairman | 73 | 23/04/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 23/09/26 | Buy | Chairman | 2,00,000 | 0.1558% | ||
| 14/09/26 | Buy | Chairman | 1,00,000 | 0.0779% | ||
| 02/09/26 | Buy | Chairman | 1,00,000 | 0.0779% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -14.29% | -62.50% | -70.00% | 27.51L | |
| -0.61% | -3.43% | +36.07% | +115.04% | 1,01900Cr | |
| -1.02% | -5.60% | +35.72% | +64.63% | 62TCr | |
| +1.11% | -0.58% | +12.36% | +77.95% | 46TCr | |
| +0.34% | -3.01% | +61.79% | +41.24% | 36TCr | |
| -0.06% | -2.73% | +19.87% | +40.13% | 33TCr | |
| +0.81% | -3.38% | +10.87% | +34.47% | 27TCr | |
| +0.11% | -4.84% | -6.58% | +9.04% | 24TCr | |
| -1.04% | -2.79% | +35.30% | +51.84% | 22TCr | |
| -1.87% | -4.10% | +28.44% | +93.66% | 18TCr | |
| Average | -0.22% | -4.62% | +17.13% | +45.80% | 36.97TCr | |
| Weighted average by Cap. | -0.26% | -3.54% | +29.01% | +70.55% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 99.23L 69.61L 61.85L 57.73L 52.62L 67Cr 1Cr 6.99Cr 2.71Cr 34Cr 2.61Cr 2.56Cr 109.79Cr | 1.21Cr 85.05L 75.57L 70.53L 64.28L 82Cr 1.22Cr 8.54Cr 3.31Cr 42Cr 3.19Cr 3.12Cr 134.14Cr |
| Net income | -27.73L -19.45L -17.28L -16.13L -14.7L -19Cr -27.99L -1.95Cr -75.65L -9.56Cr -73.04L -71.45L -31Cr | -18.41L -12.92L -11.48L -10.71L -10L -12Cr -18.59L -1.3Cr -50.23L -6.35Cr -48.5L -47.45L -20Cr |
| Net Debt | 13.75L 10L 9L 8L 7L 9.27Cr 13.88L 96.79L 37.51L 4.74Cr 36.21L 35.43L 15Cr | 15.05L 10.56L 9L 9L 8L 10Cr 15.19L 1.06Cr 41.07L 5.19Cr 39.65L 38.79L 17Cr |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/26/02 | CA$0.0300 | 0.00% | 21,000 |
| 01/26/01 | CA$0.0300 | +20.00% | 74,197 |
| 30/26/30 | CA$0.0250 | -28.57% | 1,68,038 |
| 29/26/29 | CA$0.0350 | 0.00% | 28,857 |
| 28/26/28 | CA$0.0350 | 0.00% | 6,500 |
- Stock Market
- Stocks
- HERB Stock
Select your edition
All financial news and data tailored to specific country editions
